Production of well-characterized Chikungunya virus stock and qualification of plaque reduction neturalization test

Project: Other project

Project Details

StatusFinished
Effective start/end date8/1/16 → 7/31/19

Funding

  • Moderna Therapeutics Inc: $117,874.00